Screener
Ionis Pharmaceuticals IONS Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 2,491,274 | 2,990,635 |
| Property, plant and equipment, net | 155,131 | 123,048 |
| Right-of-use assets | 231,560 | 238,549 |
| Deposits and other assets | 116,536 | 171,604 |
| Total assets | $$2,994,501 | 3,523,836 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $$47,704 | 28,082 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's deferred tax assets and other non-current assets?
- Ionis Pharmaceuticals (IONS) reported deferred tax assets and other non-current assets of $116.54M in Q2 2026.
- How has Ionis Pharmaceuticals's deferred tax assets and other non-current assets changed year-over-year?
- Ionis Pharmaceuticals's deferred tax assets and other non-current assets decreased by 11.8% year-over-year, from $132.1M to $116.54M.
- What is the long-term trend for Ionis Pharmaceuticals's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's deferred tax assets and other non-current assets has grown at a -23.9% compound annual growth rate (CAGR), from $50.03M to $12.76M.
Ask your AI about Ionis Pharmaceuticals's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude